A meta-analysis conducted by Kenya on everolimus in hepatocellular carcinoma reported that everolimus significantly increased the incidence of liver injury (higher alanine aminotransferase), stomatitis, anaemia, hyperglycaemia and pneumonitis[73]. The gene discussed is GPT; the disease is hepatocellular carcinoma.